Investigating the pre- and post-COVID-19 vaccination infection status of Iranian dental students: a cross-sectional study DOI Creative Commons
Fatemeh Owlia,

Mohammad-Javad Kargar,

Maryam Kazemipoor

et al.

Egyptian Journal of Bronchology, Journal Year: 2025, Volume and Issue: 19(1)

Published: Jan. 9, 2025

Abstract Background Dental students face a potential risk of COVID-19 exposure due to close patient contact and aerosol-generating procedures. This study explores the frequency infection among Iranian dental in 2022 following different vaccination doses. Methods A cross-sectional was used collect self-reported status. total 261 volunteered participate study. 252 valid forms were gathered, with response rate 96.55%. Data analysis performed using descriptive statistics, mean standard deviation, chi-square Fisher exact tests by Spss17 (Chicago, USA) software. Results The significantly decreased after first third doses vaccination. not very first, second, vaccine according type vaccine. Despite no significant difference rates between genders, years, or types (excluding AstraZeneca), participants who received AstraZeneca experienced more serious side effects compared those other vaccines. Conclusion Vaccination appeared reduce may have duration There based on received. Further research is needed investigate long-term effectiveness

Language: Английский

Investigating the pre- and post-COVID-19 vaccination infection status of Iranian dental students: a cross-sectional study DOI Creative Commons
Fatemeh Owlia,

Mohammad-Javad Kargar,

Maryam Kazemipoor

et al.

Egyptian Journal of Bronchology, Journal Year: 2025, Volume and Issue: 19(1)

Published: Jan. 9, 2025

Abstract Background Dental students face a potential risk of COVID-19 exposure due to close patient contact and aerosol-generating procedures. This study explores the frequency infection among Iranian dental in 2022 following different vaccination doses. Methods A cross-sectional was used collect self-reported status. total 261 volunteered participate study. 252 valid forms were gathered, with response rate 96.55%. Data analysis performed using descriptive statistics, mean standard deviation, chi-square Fisher exact tests by Spss17 (Chicago, USA) software. Results The significantly decreased after first third doses vaccination. not very first, second, vaccine according type vaccine. Despite no significant difference rates between genders, years, or types (excluding AstraZeneca), participants who received AstraZeneca experienced more serious side effects compared those other vaccines. Conclusion Vaccination appeared reduce may have duration There based on received. Further research is needed investigate long-term effectiveness

Language: Английский

Citations

0